{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:52:56Z","timestamp":1774533176807,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,31]]},"DOI":"10.7759\/cureus.19164","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T17:08:01Z","timestamp":1635700081000},"source":"Crossref","is-referenced-by-count":4,"title":["Vitiligo-Associated Autoimmune Disorders: A Woman With Vitiligo and Incipient Hypothyroidism"],"prefix":"10.7759","author":[{"given":"Sara","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli ML","year":"2020","unstructured":"Frisoli ML, Essien K, Harris JE. Vitiligo: mechanisms of pathogenesis and treatment. Annu Rev Immunol. 2020, 38:621-48. 10.1146\/annurev-immunol-100919-023531","journal-title":"Annu Rev Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1546043","article-title":"JAK-inhibitors in dermatology: current evidence and future applications","volume":"30","author":"Ciechanowicz P","year":"2019","unstructured":"Ciechanowicz P, Rakowska A, Sikora M, Rudnicka L. JAK-inhibitors in dermatology: current evidence and future applications. J Dermatolog Treat. 2019, 30:648-58. 10.1080\/09546634.2018.1546043","journal-title":"J Dermatolog Treat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4158\/ep.17.3.456","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"17","author":"Bahn RS","year":"2011","unstructured":"Bahn RS, Burch HB, Cooper DS, et al.. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011, 17:456-520. 10.4158\/ep.17.3.456","journal-title":"Endocr Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2012.01.005","article-title":"Hypothyroidism: etiology, diagnosis, and management","volume":"96","author":"Almandoz JP","year":"2012","unstructured":"Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012, 96:203-21. 10.1016\/j.mcna.2012.01.005","journal-title":"Med Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11250","article-title":"Vitiligo as the presenting manifestation of Sjogren's syndrome: case report and review of vitiligo and its associated autoimmune conditions","volume":"12","author":"Gutierrez N","year":"2020","unstructured":"Gutierrez N, Cohen PR. Vitiligo as the presenting manifestation of Sjogren's syndrome: case report and review of vitiligo and its associated autoimmune conditions. Cureus. 2020, 12:e11250. 10.7759\/cureus.11250","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14490","article-title":"Integrating neuronal involvement into the immune and genetic paradigm of vitiligo","volume":"46","author":"Al Abadie MS","year":"2021","unstructured":"Al Abadie MS, Gawkrodger DJ. Integrating neuronal involvement into the immune and genetic paradigm of vitiligo. Clin Exp Dermatol. 2021, 46:646-50. 10.1111\/ced.14490","journal-title":"Clin Exp Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-6-3","article-title":"Anti-thyroid peroxidase antibody and vitiligo: a controlled study","volume":"6","author":"Daneshpazhooh M","year":"2006","unstructured":"Daneshpazhooh M, Mostofizadeh G M, Behjati J, Akhyani M, Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol. 2006, 6:3. 10.1186\/1471-5945-6-3","journal-title":"BMC Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01633.x","article-title":"Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency","volume":"58","author":"Pedersen IB","year":"2003","unstructured":"Pedersen IB, Knudsen N, J\u00f8rgensen T, Perrild H, Ovesen L, Laurberg P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf). 2003, 58:36-42. 10.1046\/j.1365-2265.2003.01633.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2178","article-title":"Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis","volume":"97","author":"Ehlers M","year":"2012","unstructured":"Ehlers M, Thiel A, Bernecker C, et al.. Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2012, 97:1347-54. 10.1210\/jc.2011-2178","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/938257","article-title":"Association between vitiligo and thyroid autoimmunity","volume":"2011","author":"Kasumagic-Halilovic E","year":"2011","unstructured":"Kasumagic-Halilovic E, Prohic A, Begovic B, Ovcina-Kurtovic N. Association between vitiligo and thyroid autoimmunity. J Thyroid Res. 2011, 2011:938257. 10.4061\/2011\/938257","journal-title":"J Thyroid Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.39733","article-title":"Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo","volume":"53","author":"Sedighe M","year":"2008","unstructured":"Sedighe M, Gholamhossein G. Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo. Indian J Dermatol. 2008, 53:9-11. 10.4103\/0019-5154.39733","journal-title":"Indian J Dermatol"},{"key":"ref12","article-title":"High frequency of thyroid dysfunction in Indian patients with vitiligo","volume":"48","author":"Dave S","year":"2003","unstructured":"Dave S, D'Souza M, Thappa DM, Reddy KS, Bobby Z. High frequency of thyroid dysfunction in Indian patients with vitiligo. Indian J Dermatol. 2003, 48:68-72.","journal-title":"Indian J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2017.09.08","article-title":"Dermatologic manifestations of endocrine disorders","volume":"6","author":"Lause M","year":"2017","unstructured":"Lause M, Kamboj A, Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl Pediatr. 2017, 6:300-12. 10.21037\/tp.2017.09.08","journal-title":"Transl Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.07.036","article-title":"Comorbid diseases of vitiligo: a 10-year cross-sectional retrospective study of an urban US population","volume":"82","author":"Hadi A","year":"2020","unstructured":"Hadi A, Wang JF, Uppal P, Penn LA, Elbuluk N. Comorbid diseases of vitiligo: a 10-year cross-sectional retrospective study of an urban US population. J Am Acad Dermatol. 2020, 82:628-33. 10.1016\/j.jaad.2019.07.036","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12870","article-title":"Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan","volume":"29","author":"Chen YT","year":"2015","unstructured":"Chen YT, Chen YJ, Hwang CY, et al.. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2015, 29:1362-9. 10.1111\/jdv.12870","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study","volume":"74","author":"Gill L","year":"2016","unstructured":"Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016, 74:295-302. 10.1016\/j.jaad.2015.08.063","journal-title":"J Am Acad Dermatol"},{"key":"ref17","article-title":"Polycystic ovary syndrome and vitiligo: simple association or tight connection?","volume":"151","author":"Conti R","year":"2016","unstructured":"Conti R, Manni C, Colucci R, Dragoni F, Moretti S. Polycystic ovary syndrome and vitiligo: simple association or tight connection?. G Ital Dermatol Venereol. 2016, 151:715-6.","journal-title":"G Ital Dermatol Venereol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2010.00542.x","article-title":"Laser hair removal in a patient with polycystic ovarian syndrome and vitiligo","volume":"10","author":"Zainab J","year":"2011","unstructured":"Zainab J. Laser hair removal in a patient with polycystic ovarian syndrome and vitiligo. J Cosmet Dermatol. 2011, 10:72-3. 10.1111\/j.1473-2165.2010.00542.x","journal-title":"J Cosmet Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/75808-vitiligo-associated-autoimmune-disorders-a-woman-with-vitiligo-and-incipient-hypothyroidism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:27Z","timestamp":1707507147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/75808-vitiligo-associated-autoimmune-disorders-a-woman-with-vitiligo-and-incipient-hypothyroidism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.19164","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,31]]}}}